Inactive Instrument

Highlights Stratus Media Group Inc. OTC Bulletin Board

Equities

US8631651069

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2023	Diffusion Pharmaceuticals Inc.(NasdaqCM:DFFN) dropped from NASDAQ Composite Index	CI
2023	CervoMed Completes Merger with EIP Pharma	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CervoMed Completes Merger with EIP Pharma	23-08-16	MT
EIP Pharma, Inc. completed the acquisition of Diffusion Pharmaceuticals Inc. in a reverse merger transaction.	23-08-15	CI
Diffusion Pharmaceuticals Shareholders Approve Merger With EIP Pharma; Shares Rise	23-08-15	MT
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFN	23-03-31	BU
Diffusion Pharmaceuticals, EIP Pharma Agree to Merge to Create New Combined Entity	23-03-30	MT
EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases	23-03-30	AQ
EIP Pharma, Inc. entered into a definitive merger agreement to acquire Diffusion Pharmaceuticals Inc. for $22.2 million in a reverse merger transaction.	23-03-29	CI
LS Capital, Inc., on behalf of a client and unaffiliated investor in Diffusion Pharmaceuticals Inc. cancelled the acquisition of remaining shares of Diffusion Pharmaceuticals Inc..	22-11-16	CI
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Diffusion to Launch Phase 2 Trial of Trans Sodium Crocetinate in Brain Cancer By Year End	22-07-26	MT
Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation	22-07-26	CI
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial	22-06-23	CI
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Reverse Split: 1 of 50	22-04-18	FA
Diffusion Pharmaceuticals Completes Dosing in Altitude Trial	22-04-11	CI
Diffusion Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
Diffusion Pharmaceuticals Doses First Patients in ILD-DLCO Trial	21-12-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Stratus Media Group Inc. OTC Bulletin Board

Equities

US8631651069

Highlights

Filters